+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new class of antiemetic agents on the horizon

A new class of antiemetic agents on the horizon

Clinical Journal of Oncology Nursing 6(2): 103-104

This article reviews a new class of antiemetic agents, the neurokinin-1 (NK-1) receptor antagonists (RAs). Clinical trials of an NK-1 RA, aprepitant, are ongoing.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 045079398

Download citation: RISBibTeXText

PMID: 11889671

DOI: 10.1188/02.CJON.103-104

Related references

Ondansetron--the first of a new class of antiemetic agents. Clinical Pharmacy 10(6): 430-446, 1991

Serotonin antagonists: a new class of antiemetic agents. Journal of the National Cancer Institute 83(9): 613-620, 1991

Antiemetic placebo: reduce adverse drug interactions between chemotherapeutic agents and antiemetic drugs in cancer patients. Medical Hypotheses 70(3): 551-555, 2007

Successful antiemetic treatment of TSUMURA Rikkunshi-to Extract Granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 33(8): 1129-1131, 2006

Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein. Official Gazette of the United States Patent & Trademark Office Patents 1200(2): 1348, July 8, 1997

Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein us patent 4772459 september 20 1988. 1988

Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy--a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines. Supportive Care in Cancer 23(1): 273-282, 2015

Potassium channel openers antagonize the effects of class III antiarrhythmic agents in canine Purkinje fiber action potentials. Implications for prevention of proarrhythmia induced by class III agents. Japanese Heart Journal 40(5): 609-619, 2000

Antiemetic agents. Current Opinion in Oncology 4(4): 597-604, 1992

New antiemetic agents. Clinical Advances in Hematology & Oncology 3(5): 350-2, 382, 2005

Effective antiemetic agents. Medical Clinics of North America 41(2): 405-432, 1957

Type-3 serotonin receptor blockaders (5-HT3)--a new class of antiemetic preparations. Eksperimental'naia i Klinicheskaia Farmakologiia 57(4): 72-75, 1994

Third type serotonin receptor blockers (5-HT-3) as a new class of antiemetic drugs. Eksperimental'naya i Klinicheskaya Farmakologiya 57(4): 72-75, 1994

Antiemetic agents in oncological practice. Medical Journal of Australia 143(8): 327-328, 1985

A therapeutic appraisal of antiemetic agents. Gp 14(5): 125-139, 1956